Sepsis ImmunoScore®
Sepsis diagnosis and prediction of adverse outcomes
ApprovedActive
Key Facts
Indication
Sepsis diagnosis and prediction of adverse outcomes
Phase
Approved
Status
Active
Company
About Prenosis
Prenosis is a pioneering diagnostics company at the intersection of artificial intelligence and precision medicine, focused on acute care conditions like sepsis. Its core asset is the FDA De Novo authorized Sepsis ImmunoScore®, an AI diagnostic that integrates into electronic health records and is also distributed via a partnership with Roche Diagnostics. The company is built on its proprietary Immunix™ platform, which leverages a vast biobank of clinical and biomarker data to develop and validate new tools. With a seasoned leadership team and a commercially authorized product, Prenosis is positioned to address a critical, high-cost area of hospital medicine.
View full company profile